NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Yong Mong Bee
National Cancer Centre Singapore - Singapore / Singapore
Medical and Health Sciences / Endocrinology and Metabolism
AD Scientific Index ID: 4690203
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Yong Mong Bee's MOST POPULAR ARTICLES
1-)
Cardiovascular events associated with SGLT-2 inhibitors versus other glucose-lowering drugs: the CVD-REAL 2 study M Kosiborod, CSP Lam, S Kohsaka, DJ Kim, A Karasik, J Shaw, N Tangri, ... Journal of the American College of Cardiology 71 (23), 2628-2639, 2018 3762018
2-)
Potential and pitfalls of ChatGPT and natural-language artificial intelligence models for diabetes educationGGR Sng, JYM Tung, DYZ Lim, YM BeeDiabetes Care 46 (5), e103-e105, 2023992023
3-)
Low-dose levothyroxine reduces intrahepatic lipid content in patients with type 2 diabetes mellitus and NAFLDE Bruinstroop, R Dalan, Y Cao, YM Bee, K Chandran, LW Cho, SB Soh, ...The Journal of Clinical Endocrinology & Metabolism 103 (7), 2698-2706, 2018942018
4-)
Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort studyS Kohsaka, CSP Lam, DJ Kim, MA Cavender, A Norhammar, ...The Lancet Diabetes & Endocrinology 8 (7), 606-615, 2020872020
5-)
Incidence and risk factors for development of new-onset diabetes after kidney transplantationYM Bee, HC Tan, TL Tay, TYS Kee, SY Goh, PC KekAnnals of the Academy of Medicine-Singapore 40 (4), 160, 2011662011
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept